Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 649-660 of 1,136
Drug study icon
CompletedNCT01567527

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

This study exists to see whether the medication OPC-14597 can make care clearer and more responsive. Researchers are trying to understand whether the medication OPC-14597 can better prevent setbacks and support longer-term stability.

In Canada
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Japan, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Behavioral study icon
CompletedNCT04027452

Electroconvulsive Therapy for Traumatic Memories

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
PTSD, DepressionBehavioralOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
PTSD, Depression
Drug study icon
CompletedNCT02108626

Electronic Cigarettes in Daily Dependent Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
AddictionDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Addiction
Behavioral study icon
CompletedNCT05896436

Emotion Focused Therapy for Competitive Athletes

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
Anxiety, DepressionBehavioralOver 18 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Anxiety, Depression
Device study icon
CompletedNCT05555056

Enhancing the Effectiveness of Cognitive Behavioral Therapy Using Non-invasive Brain Stimulation

This study is looking at whether cognitive behavioural therapy can help people with Depression, Anxiety, or PTSD. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

In Canada
PTSD, Depression, ...DeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
Canada
Sponsor
University of Manitoba
Condition
PTSD, Depression, ...
Other study type icon
CompletedNCT00291200

Enhancing the Prospective Prediction of Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
SchizophreniaOtherFrom 12 Years to 35 Years
Countries
United States, Canada
Sponsor
Yale University
Condition
Schizophrenia
Device study icon
Active Not RecruitingNCT03788811

ERG Components in Schizophrenia and Bipolarity type I

This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Canada
Bipolarity, SchizophreniaDeviceFrom 18 Years to 50 Years
Countries
United States, Australia, Canada
Sponsor
diaMentis Inc.
Condition
Bipolarity, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.